Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis
Public ClinicalTrials.gov record NCT06742957. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site, Clinical Study to Evaluate the Therapeutic Equivalence of Tapinarof Cream 1% (Teva Pharmaceuticals, Inc.) With VTAMA® Tapinarof (Tapinarof) Cream 1% (Dermavant Sciences, Inc.) in Adult Patients With Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To compare the safety and efficacy of the test (Tapinarof Cream 1%), placebo (vehicle cream) and reference VTAMA® (Tapinarof Cream 1%) treatments to demonstrate clinical equivalence in patients with plaque psoriasis.
Study identification
- NCT ID
- NCT06742957
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 560 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 16, 2024
- Primary completion
- Oct 6, 2025
- Completion
- Nov 11, 2025
- Last update posted
- Dec 16, 2025
2024 – 2025
United States locations
- U.S. sites
- 26
- U.S. states
- 13
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 12107 | Scottsdale | Arizona | 85260 | — |
| Site 12101 | Bryant | Arkansas | 72022 | — |
| Site 12110 | Dublin | California | 94568 | — |
| Site 12112 | Dublin | California | 94568 | — |
| Site 12102 | Fremont | California | 94538 | — |
| Site 12119 | Huntington Beach | California | 92647 | — |
| Site 12120 | Northridge | California | 91325 | — |
| Site 12111 | Pomona | California | 91767 | — |
| Site 12122 | Greenwich | Connecticut | 06831 | — |
| Site 12115 | Fort Lauderdale | Florida | 33308 | — |
| Site 12104 | Miami | Florida | 33144 | — |
| Site 12116 | Miami | Florida | 33146 | — |
| Site 12113 | Miami | Florida | 33175 | — |
| Site 12114 | Miramar | Florida | 33027 | — |
| Site 12108 | Chicago | Illinois | 60614 | — |
| Site 12121 | Rolling Meadows | Illinois | 60008 | — |
| Site 12106 | Clarksville | Indiana | 47129 | — |
| Site 12123 | Merrillville | Indiana | 46410 | — |
| Site 12105 | Louisville | Kentucky | 40241 | — |
| Site 12109 | Las Vegas | Nevada | 89121 | — |
| 12127 | Woodbury | New York | 11797 | — |
| Site 12126 | Portland | Oregon | 97210 | — |
| Site 12125 | Upper Saint Clair | Pennsylvania | 15241 | — |
| Site 12103 | College Station | Texas | 77845 | — |
| Site 12118 | El Paso | Texas | 79925 | — |
| Site 12117 | Houston | Texas | 77070 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06742957, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06742957 live on ClinicalTrials.gov.